Radiotherapy, China's biotech surge and AI's role in drug discovery are notable topics that emerged from conversations on the ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

The Global Genes Corporate Alliance, an initiative that brings together biopharmaceutical companies and academic institutions working to improve access and treatments for people with rare diseases, ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

Nvidia Corporation is poised for >70% YoY growth in Q4 FY25, driven by AI dominance and a $300B healthcare opportunity.

Galapagos NV. announced its plans to split into two listed entities by mid-2025 by spinning off its activities focused on ...